Drug Testing Procurement Intelligence: Drug Testing category is expected to have pricing growth outlook of 6.5% From 2023 To 2030
Drug Testing Procurement Intelligence The drug testing category is expected to grow at a CAGR of 6.5% from 2023 to 2030. The key drivers of the market growth are the increasing consumption of alcohol by young people and the elderly, the overuse of prescribed medications, and the rising use of narcotics. The demand for drug testing is also anticipated to increase due to the increased instances of illegal drug use and the rising crime rates linked to drug misuse. There is more competition among manufacturers, and those developing innovative products across a wider range of categories are capturing a larger share of the market. Order your copy of the Drug Testing category procurement intelligence report 2023-2030 , published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis Drug Testing Procurement Intelligence Report Scope The Drug Testing category...